Rate control versus rhythm control: Choose your poison

American Heart Journal

Volumn 149, Issue 6, 2005, Pages 957-959

  Passman, Rod ^a   Kadish, Alan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CONGESTIVE HEART FAILURE; DRUG EFFICACY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PROARRHYTHMIA; HEART RATE AND RHYTHM; HEART TAMPONADE; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PULMONARY VEIN OBSTRUCTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SINUS RHYTHM; STROKE;

ATRIAL FIBRILLATION; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS;

EID: 20544469233     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.01.018     Document Type: Editorial

References (13)

1. V.E. Hagens, H. Crijns, and D. Veldhuisen Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure-results from the Rate Control versus Electrical Cardioversion (RACE) study Am Heart J 149 2005 1106 1111
2. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker The rate control versus electrical cardioversion for persistent atrial fibrillation study group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
3. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
4. M. Man-Son-Hing, A. Laupacis, and A. O'Connor Warfarin for atrial fibrillation. The patient's perspective Arch Intern Med 156 1996 1841 1848
5. N.A. Solomon, H.A. Glick, and C.J. Russo Patient preferences for stroke outcomes Stroke 25 1994 1721 1725
6. E.J. Benjamin, P.A. Wolf, and R.B. D'Agostino Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
7. The AFFIRM Investigators Relationship between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1509 1513
8. D.L. Dries, D.V. Exner, and B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction J Am Coll Cardiol 32 1998 695 703
9. S.A. Strickberger, J.D. Hummel, and T.G. Bartlett Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT J. Am. Coll. Cardiol. 41 2003 1707 1712
10. P.E. Carson, G.R. Johnson, and W.B. Dunkman The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HeFT Studies Circulation 87 Suppl 6 1993 VI 102
11. O.D. Pedersen, B. Brendorp, and H. Elming Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish investigations of arrhythmia and mortality on dofetilide/(DIAMOND) study [Journal Article] Card Electrophysiol Rev 7 2003 220 224
12. C. Pappone, S. Rosanio, and G. Augello Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study J Am Coll Cardiol 42 2003 185 197
13. L.F. Hsu, P. Jaïs, and P. Sanders Catheter ablation for atrial fibrillation in congestive heart failure N Engl J Med 351 2004 2373 2383